Acorn Regulatory To Speak at RQA Ireland Forum 2019
We will be speaking at the 2019 RQA Ireland Regional Forum on May 23rd at The Kingswood Hotel in Dublin. The 2019 event will focus on the theme of ‘Chain Reactions & Interactions’ and will look at the uncertainty that...
The Increasing PV Obligations of Scientific Literature
Scientific literature is a significant source of information for the monitoring of the safety profile of medicinal products, particularly in relation to the detection of new safety signals or emerging safety issues.
Acorn Regulatory NewsAcorn Regulatory's Top 100 ArticlesGemma RobinsonMarketing Authorisation HoldersPharmacovigilance
Pharmacovigilance & Social Media in 2019
In 2015 we looked at the emerging role of social media in pharmacovigilance. Revisiting the topic over 3 years later we are glad to say that the field has moved on substantially in terms of research into the practical applications...
Acorn Regulatory NewsAcorn Regulatory's Top 100 ArticlesGemma RobinsonHow-To & ExplainersPharmacovigilance
How Can Remote Audits Reduce Your Pharmacovigilance Costs?
Can remote audits really reduce costs for PV departments? The remote or desktop audit is growing in popularity as client companies assess costs and the environmental impact of traveling to an audit site. Furthermore, the restrictions on movement and travel...
Acorn Regulatory NewsBrexitIndustry NewsMarie CarrollMarketing Authorisation HoldersPharmaceuticalPharmacovigilance
Centralised Procedure Medicinal Products: Brexit Update
How will the UK’s departure from the EU impact on medicinal products for human and veterinary health? We have written an overview that, we hope, will serve as a handy guide. The Q & A document “Questions and Answers to...
Acorn Regulatory NewsAcorn Regulatory's Top 100 ArticlesGemma RobinsonHow-To & ExplainersIndustry NewsMDRPharmaceuticalPharmacovigilance
How Ever-Changing Regulatory Demands Will Impact Small and Emerging Pharmaceutical and Medical Device Companies
Life science companies face considerable challenges aside from developing and launching new medicinal products and medical devices. The consistent pace of change means that companies must maintain understanding of developments in the sector. In this article, we look at some...
Focus On: Our Pharmacovigilance Services
We offer a complete and comprehensive pharmacovigilance services to assist you in meeting your legal obligations as Marketing Authorisation Holder (MAH). We are here to help you with some or all of your pharmacovigilance needs.
Most Read Acorn Regulatory Pharmacovigilance Articles of 2017
It has been a very busy year for the Acorn Regulatory pharmacovigilance team. Over the course of the year we have worked with a large number of companies around the world. Our team has also produced a large number of...
What’s New in Pharmacovigilance? Get Our E-Book
Our latest pharmacovigilance e-book looks at PSUR’s, key performance indicators and more. Download the free e-book here.
Brexit and Pharmacovigilance: Notes from the DIA QPPV Conference
Delegates from the Acorn Regulatory clinical team are attending the 11th annual DIA QPPV forum in London. One of the main talking points at the conference has been the issue of Brexit and the impact that it will have on...
By using this website, you agree to our
cookie policy.
Close